Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1996-08-30
1997-09-16
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
514925, 514928, A61K 31615
Patent
active
056681232
ABSTRACT:
Method of treating venous insufficiency and venous ulcers by administering to a patient in need thereof an effective amount of sulphasalazine or 5-aminosalicylic acid.
REFERENCES:
patent: Re33239 (1990-06-01), Halskov
patent: 4970301 (1990-11-01), Rolland et al.
patent: 5010069 (1991-04-01), Bottom et al.
patent: 5384134 (1995-01-01), Kross et al.
patent: 5519014 (1996-05-01), Borody
patent: 5571843 (1996-11-01), Cugnon De Sevricourt et al.
The Merck Manual, 14th ed. p. 2033 1982.
Pooley, N. et al, "Up-Regulation of E-Selectin and Inter-cellular Adhesion Molecule-1 Differs Between Crohn's Disease and Ulcerative Colitis", Dig.Dis.Sci., vol. 40, No. 1, Jan. 1995, pp. 219-225.
Wackers, F.J.T. et al, "Necrotizing Vasculitis and Ulcerative Colitis", Brit.Med.J., No. 5936, 1974, pp. 83-84.
O'Connor, C. et al, "Prevention of Recurrent Thrombosis In Antiphospholipid Syndrome (APS)", Arthritis & Rheumatism, vol. 38, No. 9SUP, 21, Oct. 26, 1995, p. S169.
Henley III Raymond
Synthelabo
LandOfFree
Method of maintaining remission from venous ulcers with sulphasa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of maintaining remission from venous ulcers with sulphasa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of maintaining remission from venous ulcers with sulphasa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218325